Skip to main content

Borealis Foods Inc.

For the period ended Dec 31, 2025. Filed Jun 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Jun 2, 2026

BRLS$1.00+10.4%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Item 11. Executive Compensation

Our named executive officers (or “NEOs”) for the year ended December 31, 2025, consisted of five individuals:

(i)Reza Soltanzadeh, our current Chief Executive Officer, who served as our principal executive officer during the year ended December 31, 2025;
(ii)Stephen Wegrzyn, our current Chief Financial Officer, who served as our principal financial officer at the end of the fiscal year ended December 31, 2025;
(iii)Pouneh Rahimi, our Chief Legal Officer, who was serving as our executive officer at the end of the fiscal year ended December 31, 2025;
(iv)Henry Wong, our current Chief Marketing Officer, who was serving as our executive officer at the end of the fiscal year ended December 31, 2025; and
(v)Matt Talle, our current Chief Strategy Officer, who was serving as our executive officer at the end of the fiscal year ended December 31, 2025.

This section discusses the material components of the executive compensation program for our executive officers who are named in the “Summary Compensation Table” below.

This discussion may contain forward-looking statements that are based on our current plans, considerations, expectations, and determinations regarding future compensation programs.

Summary Compensation Table

The following table sets forth information regarding the compensation earned during the years ended December 31, 2025 and December 31, 2024 by our NEOs.

Name and Principal Position · Year · Salary ($) · Bonus ($) · Option Awards ($) · Stock Awards ($) · All Other Compensation ($) · Total ($)
Reza Soltanzadeh2025500,000(1)————500,000
President and Chief Executive Officer2024450,998————450,998
Stephen Wegrzyn2025178,000————178,000
Chief Financial Officer2024178,000————178,000
Pouneh Rahimi2025202,915————202,915
Chief Legal Officer2024202,915————202,915
Henry Wong2025183,365————183,365
Chief Marketing Officer2024183,365————183,365
Matt Talle2025280,110————280,110
Chief Strategy Officer2024256,110————256,110
(1)Mr. Soltanzadeh’s annual base salary for fiscal year 2025 was $500,000. Effective February 1, 2025, Mr. Soltanzadeh deferred the payment of his base salary through December 31, 2025. As of December 31, 2025, approximately $460,000 in deferred salary remained unpaid and is reflected as an obligation of the Company. See Item 13, “Certain Relationships and Related Transactions, and Director Independence.”

Narrative Disclosure to the Summary Compensation Table

Certain of the compensation paid to our NEOs reflected in the Summary Compensation Table was provided pursuant to plans and programs which are summarized below. Mr. Talle, Mr. Wegrzyn and Mr. Wong were not party to an employment agreement during 2025 or 2024. Ms. Rahimi and Mr. Soltanzadeh were each party to an employment agreement during 2024 and 2025. For a discussion of benefits, please see below.

Elements of Compensation

In 2025, our compensation program consisted primarily of the following elements: base salary and benefits.

2025 Base Salary

Historically, we have provided base salary as a fixed source of compensation for our executive officers. Base salaries for NEOs are established based on the scope of their responsibilities, competencies and their prior relevant experience, taking into account compensation paid in the market for similar positions and the market demand for such NEO’s total compensation package. Base salaries are reviewed annually and increased for merit reasons based on the executive’s success in meeting or exceeding individual objectives. Additionally, base salaries can be adjusted as warranted throughout the year to reflect promotions or other changes in the scope of breadth of an executive’s role or responsibilities, as well as to maintain market competitiveness.

Long Term Equity Compensation Plans

The Incentive Plan initially makes available a maximum number of 1,125,869 Common Shares. The aggregate number of Common Shares that is (i) issued to an officer, director, 10% shareholder and anyone who possesses material non-public information because of his or her relationship with the company or with an officer, director or principal shareholder of the company (“Insiders”) under the Incentive Plan or any other proposed or established share compensation arrangement within any one-year period will not exceed 10% of the total issued and outstanding Common Shares subject to the Incentive Plan from time to time and (ii) issuable to a non-employee director under the Incentive Plan during any of our fiscal years may not have a “fair value” as of the date of grant, as determined in accordance with ASC Topic 718 (or any other applicable accounting guidance), that exceeds $300,000 in the aggregate. No grants were made under the equity incentive plan to NEOs in 2025.

Health and Welfare Plans

Our named executive officers are eligible to participate in the employee benefit plans that we offer to our employees generally, including medical, life and accidental death and dismemberment, and short- and long-term disability benefits in Canada and the United States, and basic and extended health care, dental, counseling services, disability, life and accidental death and dismemberment insurance and survivor benefits in Canada.

Clawback Policy

We adopted a compensation recovery policy (the “Company’s Clawback Policy”), which was effective March 27, 2024, that is compliant with the Nasdaq Listing Rules, as required by the Dodd-Frank Act. A copy of the Company’s Clawback Policy was previously filed as Exhibit 97.1 to the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2024, filed with the SEC on April 15, 2025, and is incorporated herein by reference.

Outstanding Equity Awards at Fiscal Year End

As of December 31, 2025, no NEO held any outstanding equity awards.

Director Compensation

The following table sets forth compensation earned by or paid to each non-employee director for the year ended December 31, 2025.

NameFees Earned or Paid in Cash ($)Stock Awards ($)(1)Option Awards ($)All Other Compensation ($)Total ($)
Ertharin Cousin—40,125——40,125
Barthelemy Helg—40,125——40,125
Shukhrat Ibragimov—————
Steven Oyer—40,125——40,125
Shiv Vikram Khemka(2)—40,125——40,125
(1)Amounts reflect the aggregate grant date fair value computed in accordance with ASC Topic 718; the price per share value as of the closing on May 27, 2025, the grant date, was $3.21.

No non-employee directors received cash compensation for services rendered to us during the years ended December 31, 2024 and December 31, 2025. The non-employee directors received a grant of 10,000 shares under our Equity Incentive Plan for their services in year one and a grant of 2,500 shares for the first four months of year two. The grants for the balance of the year will be made in the second quarter of 2026.

(2)On May 11, 2026, Mr. Khemka resigned from the Board of Directors (the “Board”) of the Company and from his positions as a member of the Audit Committee, Compensation Committee and Nominating and Corporate Governance Committee of the Board. Mr. Khemka’s resignation was not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.

Cash Compensation

The chairperson of the three principal standing committees of our board of directors are entitled to the following annual cash retainers:

Board CommitteeChairperson Fee
Audit Committee$16,666.66
Compensation Committee$16,666.66
Nominating and Corporate Governance Committee$16,666.66

No cash retainers were paid during the year ended December 31, 2025 to the chairperson of the three standing committees of our board of directors. The sums shown above will be paid during fiscal year 2026.

We also reimburse all reasonable pre-approved out-of-pocket expenses incurred by non-employee directors for their attendance at meetings of our board of directors or any committee thereof.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.